Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Sales | 15,281,000 | 13,003,000 | 11,229,000 | 9,256,000 | 7,670,400 |
Cost of Goods | 587,000 | 461,000 | 438,000 | 420,000 | 385,900 |
Gross Profit | 14,694,000 | 12,542,000 | 10,791,000 | 8,836,000 | 7,284,500 |
Operating Expenses | 9,503,000 | 7,835,000 | 7,625,000 | 6,581,000 | 4,766,400 |
Operating Income | 5,191,000 | 4,707,000 | 3,166,000 | 2,255,000 | 2,519,000 |
Interest Expense | 741,000 | 522,000 | 500,000 | 311,000 | 176,100 |
Other Income | 382,000 | 129,000 | -294,000 | 79,000 | -15,500 |
Pre-tax Income | 4,832,000 | 4,314,000 | 2,372,000 | 2,023,000 | 2,327,400 |
Income Tax | 786,000 | 1,374,000 | 373,000 | 421,000 | 327,500 |
Net Income Continuous | 4,046,000 | 2,940,000 | 1,999,000 | 1,602,000 | 1,999,900 |
Net Income | $4,046,000 | $2,940,000 | $1,999,000 | $1,602,000 | $1,999,900 |
EPS Basic Total Ops | 5.65 | 3.77 | 2.57 | 2.02 | 2.49 |
EPS Basic Continuous Ops | 5.65 | 3.77 | 2.57 | 2.02 | 2.49 |
EPS Diluted Total Ops | 5.51 | 3.64 | 2.49 | 1.94 | 2.39 |
EPS Diluted Continuous Ops | 5.51 | 3.64 | 2.49 | 1.94 | 2.39 |
EPS Diluted Before Non-Recurring Items | 7.61 | 6.84 | 5.18 | 4.08 | 3.36 |
EBITDA(a) | $5,826,000 | $5,178,000 | $3,671,000 | $2,657,000 | $2,888,399 |